(Q48430406)

11 February 2018

title

Abeta conformational change is central to Alzheimer's disease (English)

1 reference

11 February 2018

0 references

1

David M Holtzman

1 reference

11 February 2018

publication date

1 November 2002

1 reference

11 February 2018

published in

Neurobiology of Aging

1 reference

11 February 2018

volume

23

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

1085-1088

1 reference

11 February 2018

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Evidence for genetic linkage of Alzheimer's disease to chromosome 10q

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Progress toward valid transgenic mouse models for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Susceptibility locus for Alzheimer's disease on chromosome 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Genetic neurodegenerative diseases: the human illness and transgenic models

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Apolipoprotein E and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Pathogenic effects of D23N Iowa mutant amyloid beta -protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900040-4

7 January 2021

10.1016/S0197-4580(02)00040-4

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018